Stock Comparison
ABBV vs BMY
AbbVie Inc and Bristol-Myers Squibb Company side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$447.62B
$117.46B
P/E (TTM)
123.6
16.1
Forward P/E
17.8
8.8
Price/Sales
7.1
2.4
Price/Book
50.5
5.6
EV/EBITDA
30.2
9.9
Dividend Yield
2.77%
4.51%
Profitability
Net Margin
5.79%
15.00%
Operating Margin
32.20%
33.00%
Return on Equity
62.30%
38.70%
Return on Assets
10.00%
10.70%
Growth (YoY)
Revenue Growth
12.40%
2.60%
Earnings Growth
-46.20%
9.20%
Price & Risk
Beta
0.3
0.2
52-Week High
$253.35
$62.25
52-Week Low
$176.02
$41.46
Analyst Target
$254.38
$63.08
Compare ABBV and BMY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.